The Technology Innovation Institute (TII) in Abu Dhabi has launched a Biofoundry to advance R&D in synthetic biology, focusing on genetic engineering, metabolic engineering, and bioinformatics. The facility features high-throughput robotic systems, next-generation sequencing, and advanced computational tools. TII's Biofoundry is now part of the Global Biofoundry Alliance (GBA) to foster partnerships and address shared challenges. Why it matters: This initiative positions the UAE as a key player in synthetic biology, with potential breakthroughs across healthcare, agriculture, and environmental sustainability.
KAUST held its first bio-entrepreneurship ideation workshop, "Ignite Bio", for Biological and Environmental Science and Engineering students and postdoctoral fellows. Speakers from Noor Diagnostics and Discovery, Cellestia BioTech, Kyanos Biotechnology and SaudiVax shared their experiences about the startup journey. Saudi-based startups highlighted the need for services and products not currently available in the Kingdom, such as genetic diagnostic testing and local vaccine production. Why it matters: The workshop and the highlighted startups signal growing interest and opportunities for biotech innovation and entrepreneurship within Saudi Arabia.
The Research Products Development Company (RPDC) signed an agreement with The Saudi Vaccine and Biomanufacturing Center (SVBC) to establish a research and industrial center in Saudi Arabia for vaccine and biopharmaceutical development. Supported by KACST and hosted by KAUST, the SVBC will provide a state-of-the-art facility and a training platform. Cooperation agreements were also signed with GE for equipment supply and with Fujifilm Dayosent Biotechnology for MERS-CoV treatment development. Why it matters: This initiative aims to localize vaccine and advanced treatment industries in Saudi Arabia, create technical jobs, and reduce reliance on imports in line with Vision 2030.
This article discusses the application of AI in semiconductor chip design and manufacturing, with a focus on examples such as IR-drop estimation and lithography processes. It mentions Youngsoo Shin, a KAIST professor and founder of Baum, who is an expert in this area. The article also briefly mentions panel discussion hosted by MBZUAI. Why it matters: AI-driven chip design and manufacturing could accelerate semiconductor innovation in the GCC region and beyond.
The Saudi Vaccine and Biomanufacturing Center (SVBC), the first of its kind in the Middle East, broke ground at KAUST on December 15. The center will develop vaccines and biopharmaceutical products under good manufacturing practice (GMP) standards. It is a joint project championed by the Ministry of Energy, Industry and Mineral Resources through the Industrial Clusters Program and supported by KACST. Why it matters: The center will serve as a national platform for pharmaceutical innovation and address epidemic risks in the Kingdom, such as MERS-CoV.
KAUST researchers are exploring novel chemical reactors and separation processes using mathematical design, with a focus on time and shape variables to enhance transport, heat transfer, and mass transfer. By aligning design, modeling, and 3D printing, they create customized shapes with great complexity and less material. This approach allows for the creation of bespoke reactors and separation processes tailored to specific applications, improving efficiency and reducing energy consumption. Why it matters: This research demonstrates the potential of advanced manufacturing techniques to revolutionize industrial design in the Middle East's chemical and pharmaceutical sectors.
The AI4Bio Workshop at MBZUAI explored the intersection of AI and biology, focusing on AI-driven virtual organisms and foundation models. Eric Xing presented his vision of using AI to simulate biological activities, offering a safer alternative to physical experiments. Researchers like Le Song and Jen Philippe Vert are developing foundation models for biological systems, enhancing drug discovery and bioengineering. Why it matters: This signals the growing importance of AI in advancing biological research and healthcare innovation within the UAE and globally.
KAUST researchers have developed a new synthetic biology process using metabolically engineered algae to produce fragrant sesquiterpenoids, the core compounds in agarwood and other perfumes. The process, developed by the Lauersen and Szekely groups, achieved yields 25 times higher than previous methods and allows for the synthesis of 103 types of fragrant sesquiterpenoids. It also incorporates an energy-efficient nanofiltration step and operates at room temperature with minimal waste. Why it matters: This sustainable bioprocess offers a green alternative to environmentally damaging harvesting of natural resources for the $44 billion fragrance industry, with potential applications in drug development.